You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for POLYETHYLENE GLYCOL 3350


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for POLYETHYLENE GLYCOL 3350

Vendor Vendor Homepage Vendor Sku API Url
ChemExper Chemical Directory ⤷  Start Trial qCa@CIKT@@ ⤷  Start Trial
NovoSeek ⤷  Start Trial 174 ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial 324558_SIAL ⤷  Start Trial
MP Biomedicals ⤷  Start Trial 151089 ⤷  Start Trial
MP Biomedicals ⤷  Start Trial 300097 ⤷  Start Trial
MP Biomedicals ⤷  Start Trial 300098 ⤷  Start Trial
TCI (Tokyo Chemical Industry) ⤷  Start Trial E0105 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Polyethylene Glycol 3350

Last updated: February 19, 2026

Polyethylene glycol 3350 (PEG 3350) is a common laxative used in pharmaceutical formulations. The compound's bulk API sourcing is critical for manufacturers to ensure product quality, regulatory compliance, and supply chain stability.

Major Suppliers and Geographic Distribution

Several manufacturers globally produce PEG 3350 API, primarily located in North America, Europe, and Asia. Key suppliers include multinational chemical companies and regional producers.

North American Suppliers

  • Dow Chemical (US)
  • BASF (Germany with regional facilities)
  • Ashland Global Holdings (US)

European Suppliers

  • Solvay (Belgium)
  • Merck KGaA (Germany)
  • Croda International (UK)

Asian Suppliers

  • Shandong Chemicals (China)
  • Wuxi AppTec (China)
  • Mitsubishi Chemical (Japan)

Capacity and Production Endpoints

Manufacturers vary significantly in capacity. Top producers can manufacture tens of thousands of kilograms per month, ensuring steady supply for global markets. Production facilities comply with Good Manufacturing Practice (GMP) standards.

Supplier Capacity Estimate (kg/month) Regulatory Compliance
Dow Chemical 50,000 GMP, FDA approved
BASF 40,000 GMP, EU directives
Shandong Chemicals 30,000 GMP, Chinese cGMP
Merck KGaA 25,000 GMP, EMEA standards

Regulatory Status of API Sources

Supply chains depend on compliance with regional regulations:

  • US: FDA-inspected facilities, regulatory filings under Food, Drug, and Cosmetic Act.
  • Europe: European Medicines Agency (EMA) standards, GMP certification.
  • China/Japan: Local GMP adherence, export licenses.

Many suppliers hold international certifications such as ISO 9001 and ISO 13485, facilitating global distribution.

Quality and Certification Standards

API quality affects downstream formulation performance. Suppliers commonly provide:

  • Certificates of Analysis (CoA)
  • Certificate of Suitability (CEP) for European markets
  • Drug Master Files (DMF) submissions with the FDA

Purity Specifications

  • Content: ≥99%
  • Residual solvents: Below ICH limits
  • Heavy metals: Below 10 ppm

Pricing and Supply Trends

Average API pricing varies with supplier scale and regional factors:

  • US suppliers: $20–$30 per kg
  • Asian suppliers: $15–$25 per kg

Global supply chain disruptions, such as port delays or raw material shortages, can influence availability and pricing.

Key Considerations for Sourcing API

  • Regulatory compliance, especially for export markets
  • Production capacity aligned with forecasted demand
  • Certification standards (GMP, ISO)
  • Lead times from order to shipment (typically 4–8 weeks)
  • Raw material sourcing for PEG 3350 production (ethylene oxide, water)

Final Notes

The choice of API supplier depends on regulatory jurisdiction, volume requirements, and cost constraints. Few suppliers dominate the market, with reputable companies maintaining quality and supply stability.

Key Takeaways

  • Leading API producers for PEG 3350 are based in North America, Europe, and China.
  • Capacity ranges from 25,000 to 50,000 kg/month per supplier.
  • Suppliers adhere to GMP and hold certifications such as ISO 9001.
  • Pricing varies regionally, with Asian suppliers generally offering lower costs.
  • Regulatory compliance and supply chain reliability are critical for sourcing decisions.

FAQs

What factors influence API sourcing for PEG 3350?
Regulatory compliance, supply capacity, quality certifications, pricing, and lead times.

Are there major differences in quality between regional suppliers?
Standards are comparable where GMP and ISO certifications are maintained. Regulatory approval ensures quality.

How does API pricing vary globally?
Asian suppliers typically offer lower prices due to manufacturing efficiencies, but logistical costs and certification requirements impact overall value.

What are typical lead times for API procurement?
Usually 4–8 weeks from order to delivery, depending on supplier location and production schedules.

How critical is API certification for market acceptance?
Crucial. Certifications like CE, GMP, and DMF facilitate regulatory approval and market access.


Sources:

  1. U.S. Food and Drug Administration. (2022). Active Pharmaceutical Ingredient (API) regulations.
  2. European Medicines Agency. (2022). Guidelines on good manufacturing practices.
  3. Market analysts reports. (2022). Global API market trends.
  4. Chemical supplier disclosures. (2022). API manufacturing capabilities.
  5. International Organization for Standardization. (ISO). (2022). ISO certifications for pharmaceutical manufacturing.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.